Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy

Overview of attention for article published in International Journal of Nanomedicine, May 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (70th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 54 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

PD-1 single domain antibodies and therapeutic compositions thereof

Grant US-11945869-B2

United States of America

Compositions and methods related to tumor activated antibodies targeting PSMA and…

Grant US-11555078-B2

United States of America

COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARGETING PSMA AND…

Application WO-2022125576-A1

World Intellectual Property Organisation (WIPO)

PD-1 single domain antibodies and therapeutic compositions thereof

Grant US-11208485-B2

United States of America